Insulin Delivery Devices Market Analysis and Future Forecast

Publisher: Renub Research Published: June, 2009

Report Details
Insulin Delivery Devices Market Analysis and Future Forecast published by Renub Research gives a detailed analysis on the global insulin market. The report analyses and forecast on market size of different insulin delivery devices i.e. global insulin pen market, insulin pump market, insulin syringe market and insulin jet injector market. The report investigates insulin delivery devices market on the country level as well. Countries covered in the report are: for Insulin pen market US, Europe, India and Japan; Insulin pump market US and India; Insulin syringe market US and India; Insulin jet injector market US. After analyzing data from different sources we have come to conclusion that insulin pen is the most preferred mode of injecting insulin globally. Though the insulin syringes are still popular it is ceding market share rapidly to insulin pen and pump. Currently insulin pen leads the market segment but in the future insulin pump will dominate the market, as there is lot of R&D going on for improving it. Insulin pen are popular in Europe and Japan while insulin pumps are gaining popularity in US, fast replacing the dominance of insulin syringe in the market. Even developing countries like India are adapting the insulin pen for its growth going forward. Among future devices oral insulin and implantable insulin pump have bright future. Key Questions Answered in this Report What is the present and future market size of insulin pen, insulin pump, insulin syringe and insulin jet injector globally? What is insulin delivery devices market in 2007 and 2014 for Europe? What is the present and future forecast of US, Europe and India insulin pen market? What is the market share of companies in global pump market? What is the present and future forecast of US insulin pump market? Which company will control the US pump market in future? What is oral insulin market of US? What is the future of insulin patch, oral insulin and implantable insulin pump?

Renub Research

Page 2 of 14

Report Highlights Globally by 2007 insulin pen controls more than 50 percent of market share in insulin delivery devices market. In 2006 insulin pen market share in Europe and Japan was more than 85 percent. Global insulin pump and disposables market is expected to grow with a double digit figure. By 2009 companies Disetronic and MiniMed together are expected to control more than 70 percent of the insulin pump market globally. US insulin pen is forecasted to grow at a CAGR of 11.96 percent from 2006 to 2010. US insulin syringe market is expected to show a negative CAGR of -0.7 from 2007 to 2009. US insulin pump market is expected to grow with a CAGR of 11.8 percent from 2002 to 2009. European insulin pen market is expected to grow further but its market share is expected to decline from 89.7 percent in 2007 to 70.6 percent in 2014. Key Company Profiles This section provides business overview and key financial information of the companies listed: Novo Nordisk A/S, Sanofi-Aventis, Becton, Dickinson and Company, GlaxoSmithKline plc, Amylin Pharmaceuticals, Inc., Merck & Co., Inc., Eli Lilly and Company. Data Sources Information and data in this report has been collected from various printable and nonpintable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, News websites Government Agencies and Trade associations.

Renub Research

Page 3 of 14

About Us
Renub Research
in international is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have more than 7 years of experience especially Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in todays ultra-competitive markets.

For more information on us or to view any of our sample work you can mail us at info@renub.com

Renub Research

Page 4 of 14

Published By Renub Research A116B, Sector27 Noida 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: info@renub.com www.renub.com

Insulin Delivery Devices Market Analysis and Future Forecast Renub Research, 2009 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers

Renub Research

Page 5 of 14

Table of Contents
1. 2. Executive Summary Global Insulin Market

2.1 2.2
3.

Global Insulin Market Growth Prospects Global Insulin Delivery Devices Market Global Insulin Pen Key Players

Global Insulin Pens Market

3.1.1 3.2 3.3 3.4 3.5

4.

US Insulin Pen Market Europe Insulin Delivery Devices & Insulin Pen Market India Insulin Pen Market Japan Insulin Pen Devices Market Global Insulin Pump Key Players US Insulin Pumps Market Key Players Outside US Insulin Pump Market India Insulin Pump Market Europe Insulin Pump - Key Companies US Insulin Syringe Market US Insulin Jet Injectors Market Insulin Patch Oral Insulin US Oral Insulin Market Implantable Insulin Pump Novo Nordisk A/S Sanofi-Aventis Becton, Dickinson and Company GlaxoSmithKline plc Amylin Pharmaceuticals, Inc.

Global Insulin Pumps Market

4.1 4.2 4.3 4.4 4.5

5.

4.2.1

Global Insulin Syringe Market

5.1
6.

Global Insulin Jet Injectors Market

6.1
7.

Future Insulin Devices

7.1 7.2 7.3

8.

7.2.1

Key Company Profiles

8.1 8.2 8.3 8.4 8.5

Renub Research

Page 6 of 14

8.6 8.7

Merck & Co., Inc. Eli Lilly and Company

Renub Research

Page 7 of 14

List of Figures:
Figure 2-1: Global Insulin Market (in Billion USD), 2005 2007 Figure 2-2: Global Insulin Market (Billion USD), 2008 2012 Figure 3-3: Global Key Players Insulin Pen Market Shares (Percent), 2006 Figure 3-4: US Insulin Pens Market (Million USD), 2003 2006E Figure 3-5: US Forecast for Insulin Pens Market (Million USD), 2007 2010 Figure 3-7: Europe Insulin Delivery Devices Market (USD Million), 2000, 2007 & 2014 Figure 3-8: Europe - Percentage of Insulin Units Delivered in Pen Devices (Percent), 1996, 2000, 2004, 2006 & 2007E Figure 3-9: Europe - Insulin Pen Devices Market (Million USD), 2007 2014 Figure 3-10: Europe Volume Share of Disposable Pens & Other Pens, (in Percent), 2006 Figure 3-12: India Market Share of Normal Syringes & Pen Delivery Systems (in Percent), 2007 Figure 3-13: Japan Insulin Pen Devices (Percent), 1996, 2000, 2004 & 2006 Figure 4-2: Global Growth Rate of Insulin Pump and Disposables Market (in Percent), 2002 2009F Figure 4-4: US Insulin Pump and Disposables Market Growth Rate (in Percent), 2002 2009F Figure 4-5: US - Pumps & Disposable Market Revenue (Million USD), 2002 2009F Figure 4-8: US - Cumulative Number of Insulin (Type 1 Pump & Type 2 Pump) Sales (000 Units) 2002 2009F Figure 4-10: Global (Outside US) - Insulin Pump and Disposables Market (Million USD), 2002 -2009F Figure 4-11: Global (Outside US) - Insulin Pump and Disposables Market (Percent), 2002 2009F Figure 4-12: Global Market Share of US and Outside US in the Insulin Pumps & Disposables Market (in Percent), 2002 -2009F Figure 4-13: India Number of Insulin Pump Devices (Units), 2005E Figure 4-14: India Insulin Pump Market (INR Million), 2005 Figure 4-15: Europe Key Companies (Medtronic, Distronic) Insulin Pump Market (Percent), 2003 Figure 5-2: US - Insulin Syringe Market (Million USD), 2003 2006E Figure 5-3: US Forecast for Insulin Syringe Market (Million USD), 2007 2010 Figure 6-3: US Insulin Jet Injectors Market (Million USD), 2003 2006E Figure 7-1: US - Forecast for Oral Insulin Market (Million USD), 2007 2010

Renub Research

Page 8 of 14

List of Tables:
Table 4-1: Global Key Companies Market Share of Insulin Pumps (in Percent), 2002 2009F Table 4-3: US Key Companies Market Share of Total Pump Units Sold (New and Replacement) (in Percent), 2002 2009F Table 8-1: Novo Nordisk A/S - Key Financials (Million USD), 2006 2008 Table 8-2: Sanofi-Aventis - Key Financials (Million USD), 2006 2008 Table 8-3: Becton, Dickinson and Company - Key Financials (Million USD), 2006 2008 Table 8-4: GlaxoSmithKline plc - Key Financials (Million USD), 2006 2008 Table 8-5: Amylin Pharmaceuticals, Inc. - Key Financials (Million USD), 2006 2008 Table 8-6: Merck & Co., Inc. - Key Financials (Million USD), 2006 2008

Renub Research

Page 9 of 14

Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com

Format
Report Title: Insulin Delivery Devices Market Analysis and Future Forecast

Single Users (Email from publisher) US$ 850

Hard Copy (Mail Delivery) US$ 850

CD-Rom (Mail Delivery) US$ 850

Global Site License (Multiple Users License) US$ 1,100

For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.): http://renub.com/reports/showdetails.aspx?id=14 2) Order by Wire Transfer: http://renub.com/reports/wiretransfer.aspx?id=14&pid=1052 To pay by Wire Transfer, please, fill in your contact details in the form below:

Renub Research

Page 10 of 14

Bank Details
Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi 110001 India

Contact Information
First Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message: Last Name:

Renub Research

Page 11 of 14

3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research A -116B Sector -27 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us

Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

Renub Research

Page 12 of 14

Our Partial List of Clients

Redbus Becton Dickinson Pfizer Intercell Sanofi Pasteur Stanford Burgess Pequot Capital DMI Transgene S.A. ixia communications Toyota Tsusho Amercia Inc. National Health Research Institutes Abbott Diabetes Care Corning Incorporated - Life Sciences L.E.K. Consulting GmbH Syntiron MediVas LLC Credit Suisse Dune Medical QIAGEN Inje University Mapp Biopharmaceutical Institute for Information Industry NorDiag ASA Rep e Inv Medicas SA de Innogenetics

Bain WAKE Technology Services, Inc. PSS World Medical Relypsa C&K components Konkuk University Resonetics Samsung SEKISUI MEDICAL CO. LTD. Plentyoffish Media INC Arthur D Little Gmbh Morgan Stanley Takeda Pharmaceutical Corporation Hokkai School of Commerce Ministry of Manpower Singapore GenOmind, LLC. Goldman Sachs & Co NTT Advanced Technology Tokyo Womens Medical University The Chemo-Sero-Therapeutic Research Trade Council of Iceland Jpmorgan, Ets Trading GE Healthcare IT ixia communications

Renub Research

Page 13 of 14

Disclaimer
Most of the information available in this report is within the public domain. The submitting authors or other copyright holders retain rights for reproduction or redistribution. All persons reproducing or redistributing this information are expected to adhere to the terms and constraints invoked by the copyright holder. Such protected material, however, may be used under the terms of "fair use as defined in the copyright laws, which generally permit use for non-commercial educational purposes such as teaching, research, criticism, and news reporting. With respect to documents available, neither the company nor any of its employees makes any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Unless otherwise stated, the copyright, database rights, and similar rights in all material published on this manual is solely owned by Renub Research. You are permitted to print or download extracts from this material for your personal use only. None of this material may be used for any commercial or public use. No part of this manual or any material appearing may be reproduced, stored in or transmitted on any other Web site without written permission of www.renub.com and any payments of a specified fee. Requests to republish any material may be sent to us at info@renub.com.

Renub Research

Page 14 of 14